McHugh, Jana http://orcid.org/0000-0002-8210-6188
Saunders, Edward J.
Dadaev, Tokhir http://orcid.org/0000-0002-8268-0438
McGrowder, Eva
Bancroft, Elizabeth
Kote-Jarai, Zsofia
Eeles, Rosalind http://orcid.org/0000-0002-3698-6241
Funding for this research was provided by:
The NIHR Biomedical Research Centre at the Royal Marsden NHS Foundation Trust / Institute of Cancer Research, Prostate Cancer UK and The Movember Foundation.
Article History
Received: 10 May 2021
Revised: 2 November 2021
Accepted: 3 December 2021
First Online: 18 December 2021
Ethics approval and consent to participate statement
: Not applicable.
: JMcH, ES, TD, EMcG, EB and ZK-J declare no competing interests. RE: GU-ASCO meeting, San Francisco, USA, January 2016, honorarium as speaker. The Royal Marsden NHS Foundation Trust, Genetics and Prostate Cancer, November 2017, support from Janssen, honorarium as speaker. University of Chicago, Chicago Illinois, USA, May 2018, honorarium as invited speaker. ESMO Meeting, Barcelona, Spain, Treatment Sequencing for mCRPC patients within the changing landscape of mHSPC-GU Connect, September 2019, educational honorarium paid by Bayer and Ipsen AstraZeneca UK Limited, UK, Prostate Dx Advisory Panel, June 30, 2020 member of the external Expert Committee, May 2021.